My Gift to all of you - ZLAB is a stock that should consider buying now

That’s enough for me …it is weird you claim to follow the data and charts and then ignore it when it doesn’t suit politics.
You are misinformed. I do not ignore data and charts. What I do is compare/measure the positives and the negatives and if the negatives are more than the positives, I key on the negatives (opposite is also true).

as far as it being enough for you, that is fine with me.

I dislike intensely when (as you say) data, statistics and facts are ignored. You have totally ignored those I have supplied, while keying on those you have cherry picked.

For example, why on earth would you ignore this fact?

Multiple studies have concluded that many of the deaths in the US were avoidable. An assessment published in the Lancet in February 2021 concluded that 40 percent of the COVID‐19 fatalities up to that point could have been averted (Woolhandler et al., 2021, p. 711), and a Columbia University report conservatively estimated that between 130,000 and 210,000 deaths were attributable to the failures of the US government (in other words, Trump).

When it comes to "unnecessary" deaths, even 1 death is too many (compared to the benefits to the economy).
 

ZLAB - A stock that you all should consider buying​


ZLAB is a Chinese Bio-Pharma company that traded as high as 193.54 (4 years ago) and is now trading at 34.00 (with a low made 16 months ago at 13.48.

The stock went down because the company being a Bio-Pharma company developing new medicines, was always in the red (re earnings and expenses). Nonetheless, during this time, the company has been successful in developing new medicines that in some cases have now been designated by China as "innovative" and likely to become established as needed medicines for things like Cancer, when all phases have shown success.

Some 2 years ago (when the stock got down to the lows), it was because the company required additional funds for generating sales of its products. That is now mostly over as some of its medicines are now starting to be used.

This BioPharma company has a market capitalization of $4.07 billion dollars, meaning that it is the 23rd largest Biopharma company in China.

Here is an AI generated future outlook for the company:

ZLAB has a positive future outlook with analysts projecting strong revenue growth and potential profitability within the next few years. Analysts are optimistic about the company's growth prospects, citing its expanding commercial portfolio, strong pipeline, and strategic focus o both the Chinese and global markets.

Citi has a buy rating on the company with a 12-month price target of $66

Chart-wise, since the low was made back in April 2024, the chart shows a clear up channel with 4 weekly closing points showing the bottom of the channel being presently at 33.22. The top of the channel has 2 points on it, and it shows the top of the channel presently being around the $50, a level that should be reached within the next 2-4 months.

The stock is presently oversold, meaning it is ready to buy now.

A weekly close below 32.73 would break the bottom of the channel, meaning that a purchase around here would offer a risk of approximately $125, versus a profit potential of $3200 (per 100 shares).

In my opinion, this is a BUY here and now.


Good Luck to all of you.
The stock closed at 35.04 on Friday. If you purchased the stock when I mentioned it (around the 34.00 level, you would already be up 3% (in 2 days).

Here is the chart analysis I did today on the stock:

ZLAB generated an outside week with a higher high and a lower low than the previous week’s trading range. The stock did generate a red weekly close and a close slightly in the lower half of the week’s trading range, suggesting a slightly higher chance of going below last week’s low at 33.31 than above last week’s high at 36.77. Having said that and in looking at the daily chart, on Friday the stock closed on the high of the day, suggesting further upside above Friday’s high at 35.15 will be seen on Monday, meaning the week is likely to start on a positive note. It is clearly defined though, that last week’s trading range is key for this week. A break below 33.31 will strongly suggest that the 200-day MA, currently at 31.81, will be visited. On the other side of the coin, a break above 36.77 would suggest 39.77 will be visited. The monthly close is on Friday and so far the stock is having an inside month, with the high of the month being 39.64 and the low being 33.17. The stock is in an uptrend and the 36.14 level has “some” meaning (but somewhat minor) for the monthly close. A close above that level would keep the uptrend totally alive. A close above 37.40 would add ammunition to the bull’s arsenal. A close below 30.14 would derail the uptrend.
 
conservatively estimated that between 130,000 and 210,000 deaths were attributable to the failures of the US government (in other words, Trump).


MORE FAKE NEWS

The Commander acted on the best advice offered by experts and specialists . Who deliberately lied
That is what Commanders are there to do--- act on best available advice .

Your comments are just a pathetic way of continuing your hollow and deliberately fake attack on an individual .

Truly Un American and very FAKE
Muck from Mucky , as we say .
 
The stock closed at 35.04 on Friday. If you purchased the stock when I mentioned it (around the 34.00 level, you would already be up 3% (in 2 days).

Here is the chart analysis I did today on the stock:

ZLAB generated an outside week with a higher high and a lower low than the previous week’s trading range. The stock did generate a red weekly close and a close slightly in the lower half of the week’s trading range, suggesting a slightly higher chance of going below last week’s low at 33.31 than above last week’s high at 36.77. Having said that and in looking at the daily chart, on Friday the stock closed on the high of the day, suggesting further upside above Friday’s high at 35.15 will be seen on Monday, meaning the week is likely to start on a positive note. It is clearly defined though, that last week’s trading range is key for this week. A break below 33.31 will strongly suggest that the 200-day MA, currently at 31.81, will be visited. On the other side of the coin, a break above 36.77 would suggest 39.77 will be visited. The monthly close is on Friday and so far the stock is having an inside month, with the high of the month being 39.64 and the low being 33.17. The stock is in an uptrend and the 36.14 level has “some” meaning (but somewhat minor) for the monthly close. A close above that level would keep the uptrend totally alive. A close above 37.40 would add ammunition to the bull’s arsenal. A close below 30.14 would derail the uptrend.
31.62

-0.01

(-0.03%)

At close: September 26 at 4:00:00 PM ED

What were saying Banker? LOL If I followed your USMB stock tips, I might have to go back to work. :auiqs.jpg:
 
31.62

-0.01

(-0.03%)

At close: September 26 at 4:00:00 PM ED

What were saying Banker? LOL If I followed your USMB stock tips, I might have to go back to work. :auiqs.jpg:
The wanker is pretty pathetic with his recommendations.

I haven't seen a single one that did well.
 

ZLAB - A stock that you all should consider buying​


ZLAB is a Chinese Bio-Pharma company that traded as high as 193.54 (4 years ago) and is now trading at 34.00 (with a low made 16 months ago at 13.48.

The stock went down because the company being a Bio-Pharma company developing new medicines, was always in the red (re earnings and expenses). Nonetheless, during this time, the company has been successful in developing new medicines that in some cases have now been designated by China as "innovative" and likely to become established as needed medicines for things like Cancer, when all phases have shown success.

Some 2 years ago (when the stock got down to the lows), it was because the company required additional funds for generating sales of its products. That is now mostly over as some of its medicines are now starting to be used.

This BioPharma company has a market capitalization of $4.07 billion dollars, meaning that it is the 23rd largest Biopharma company in China.

Here is an AI generated future outlook for the company:

ZLAB has a positive future outlook with analysts projecting strong revenue growth and potential profitability within the next few years. Analysts are optimistic about the company's growth prospects, citing its expanding commercial portfolio, strong pipeline, and strategic focus o both the Chinese and global markets.

Citi has a buy rating on the company with a 12-month price target of $66

Chart-wise, since the low was made back in April 2024, the chart shows a clear up channel with 4 weekly closing points showing the bottom of the channel being presently at 33.22. The top of the channel has 2 points on it, and it shows the top of the channel presently being around the $50, a level that should be reached within the next 2-4 months.

The stock is presently oversold, meaning it is ready to buy now.

A weekly close below 32.73 would break the bottom of the channel, meaning that a purchase around here would offer a risk of approximately $125, versus a profit potential of $3200 (per 100 shares).

In my opinion, this is a BUY here and now.


Good Luck to all of you.
/—/ I’ve always been burned with bio tech stocks.
 
You are misinformed. I do not ignore data and charts. What I do is compare/measure the positives and the negatives and if the negatives are more than the positives, I key on the negatives (opposite is also true).
Do you compare Communist controlled to freedom, companies that are free.
 

ZLAB - A stock that you all should consider buying​


ZLAB is a Chinese Bio-Pharma company that traded as high as 193.54 (4 years ago) and is now trading at 34.00 (with a low made 16 months ago at 13.48.

The stock went down because the company being a Bio-Pharma company developing new medicines, was always in the red (re earnings and expenses). Nonetheless, during this time, the company has been successful in developing new medicines that in some cases have now been designated by China as "innovative" and likely to become established as needed medicines for things like Cancer, when all phases have shown success.

Some 2 years ago (when the stock got down to the lows), it was because the company required additional funds for generating sales of its products. That is now mostly over as some of its medicines are now starting to be used.

This BioPharma company has a market capitalization of $4.07 billion dollars, meaning that it is the 23rd largest Biopharma company in China.

Here is an AI generated future outlook for the company:

ZLAB has a positive future outlook with analysts projecting strong revenue growth and potential profitability within the next few years. Analysts are optimistic about the company's growth prospects, citing its expanding commercial portfolio, strong pipeline, and strategic focus o both the Chinese and global markets.

Citi has a buy rating on the company with a 12-month price target of $66

Chart-wise, since the low was made back in April 2024, the chart shows a clear up channel with 4 weekly closing points showing the bottom of the channel being presently at 33.22. The top of the channel has 2 points on it, and it shows the top of the channel presently being around the $50, a level that should be reached within the next 2-4 months.

The stock is presently oversold, meaning it is ready to buy now.

A weekly close below 32.73 would break the bottom of the channel, meaning that a purchase around here would offer a risk of approximately $125, versus a profit potential of $3200 (per 100 shares).

In my opinion, this is a BUY here and now.


Good Luck to all of you.
It was a gift if you short sold it. $34 when you posted, $26 now.
 
It has fall to $26.12 this morning. Another great call by Luckyone

I think whatever he picks we should do the opposite. How many times has he predicted a market crash? He told me for sure Harris was going to win the election, and called me names for not agreeing! He is just a dummy, can’t trust anything he says and is always trying to stir up hate and belittle others. Sad human.
 
It has fall to $26.12 this morning. Another great call by Luckyone

I think whatever he picks we should do the opposite. How many times has he predicted a market crash? He told me for sure Harris was going to win the election, and called me names for not agreeing! He is just a dummy, can’t trust anything he says and is always trying to stir up hate and belittle others. Sad human.
/----/ I think Jim Cramer gets his stock picks from Luckyone.
1761588696944.webp
 
If you purchase a stock for $34, only to piss and moan and cry like a ***** when it drops to $26, you have no business in the stock market, and the truth is, most of you commenting don't have anything in the market, and know nothing about investing.

We have almost no one in the forum recommending anything specific, ESPECIALLY the Trumpian crowd, none of whom sound like investors when they post here.
 
15th post
If you purchase a stock for $34, only to piss and moan and cry like a ***** when it drops to $26, you have no business in the stock market, and the truth is, most of you commenting don't have anything in the market, and know nothing about investing.

We have almost no one in the forum recommending anything specific, ESPECIALLY the Trumpian crowd, none of whom sound like investors when they post here.
/—-/ I’m an active trader since 1978.
 
If you purchase a stock for $34, only to piss and moan and cry like a ***** when it drops to $26, you have no business in the stock market, and the truth is, most of you commenting don't have anything in the market, and know nothing about investing.

We have almost no one in the forum recommending anything specific, ESPECIALLY the Trumpian crowd, none of whom sound like investors when they post here.
True, the Trumpian crowd leaves the stock pump and dumping to the Democrat crowd.
 
Back
Top Bottom